ID
45572
Description
Principal Investigator: Glen Weiss, MD, Translational Genomics Research Institute, Phoenix, AZ, USA MeSH: Carcinoma https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000657 In this study, we used NGS to identify somatic events in advanced stage cancer patients to demonstrate the feasibility for using this approach to improve patient treatment.
Lien
Mots-clés
Versions (1)
- 24/01/2023 24/01/2023 - Dr. Christian Niklas
Détendeur de droits
Glen Weiss, MD, Translational Genomics Research Institute, Phoenix, AZ, USA
Téléchargé le
24 janvier 2023
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
dbGaP phs000657 NGS in Advanced Cancers
Subject ID, sample ID, and sample use variables obtained from participants of the "A Pilot Study Using Next Generation Sequencing in Advanced Cancers: Feasibility and Challenges" project.
- StudyEvent: SEV1
- Subject ID, consent group, and type of research where were involved participants of the "A Pilot Study Using Next Generation Sequencing in Advanced Cancers: Feasibility and Challenges" project.
- Subject ID, sample ID, and sample use variables obtained from participants of the "A Pilot Study Using Next Generation Sequencing in Advanced Cancers: Feasibility and Challenges" project.
- Subject ID, age, sex, and race of participants of the "A Pilot Study Using Next Generation Sequencing in Advanced Cancers: Feasibility and Challenges" project.
- Sample ID, body site where sample was collected, analyte type, tumor status of sample, histological type of sample, primary tumor, metastasis, or transformed cell line, and primary tumor location of participants of the "A Pilot Study Using Next Generation Sequencing in Advanced Cancers: Feasibility and Challenges" project.
Similar models
Subject ID, sample ID, and sample use variables obtained from participants of the "A Pilot Study Using Next Generation Sequencing in Advanced Cancers: Feasibility and Challenges" project.
- StudyEvent: SEV1
- Subject ID, consent group, and type of research where were involved participants of the "A Pilot Study Using Next Generation Sequencing in Advanced Cancers: Feasibility and Challenges" project.
- Subject ID, sample ID, and sample use variables obtained from participants of the "A Pilot Study Using Next Generation Sequencing in Advanced Cancers: Feasibility and Challenges" project.
- Subject ID, age, sex, and race of participants of the "A Pilot Study Using Next Generation Sequencing in Advanced Cancers: Feasibility and Challenges" project.
- Sample ID, body site where sample was collected, analyte type, tumor status of sample, histological type of sample, primary tumor, metastasis, or transformed cell line, and primary tumor location of participants of the "A Pilot Study Using Next Generation Sequencing in Advanced Cancers: Feasibility and Challenges" project.
C1524063 (UMLS CUI [1,2])
Aucun commentaire